======= PITPNB ======= == Gene Information == * **Official Symbol**: PITPNB * **Official Name**: phosphatidylinositol transfer protein beta * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23760|23760]] * **UniProt**: [[https://www.uniprot.org/uniprot/P48739|P48739]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PITPNB&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PITPNB|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606876|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the transfer of PtdIns and phosphatidylcholine between membranes. |IP trans| |phosphatidylcholine transporter activity| |phosphatidylinositol transfer activity| |phosphatidylcholine binding| |retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum| |phosphatidylinositol binding| |phospholipid transport| |organophosphate ester transport| |nucleus organization| |lipid transport| |lipid localization| |Golgi vesicle transport| |organic anion transport| |anion transport| |Golgi membrane| |endoplasmic reticulum membrane| |lipid metabolic process| |ion transport| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-4.67| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-3.06| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-2.87| |[[:results:exp131|L-74142 5μM R03 exp131]]|-2.12| |[[:results:exp495|IWR1 50μM R08 exp495]]|-2.04| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-1.85| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-1.84| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-1.77| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|1.81| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|2.26| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|4.38| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|6.63| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|8| ^Gene^Correlation^ |[[:human genes:r:rab11a|RAB11A]]|0.48| |[[:human genes:t:trappc10|TRAPPC10]]|0.433| |[[:human genes:t:trappc9|TRAPPC9]]|0.426| |[[:human genes:t:tm9sf2|TM9SF2]]|0.4| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18880 * **Expression level (log2 read counts)**: 6.58 {{:chemogenomics:nalm6 dist.png?nolink |}}